Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets open in 12 minutes
ALL ORDS
7,831.90
-100.10
(-1.26%)
AUD/USD
0.6531
+0.0003
(+0.05%)
ASX 200
7,569.90
-94.20
(-1.23%)
OIL
79.06
+0.06
(+0.08%)
GOLD
2,330.80
+19.80
(+0.86%)
Bitcoin AUD
89,443.05
-3,458.87
(-3.72%)
Cellectar Biosciences Inc (NV4.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.9000
-0.0200
(-0.68%)
At close: 08:08PM CEST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
28,211
28,211
19,220
17,586
10,141
Selling general and administrative
10,749
10,749
9,594
6,545
5,150
Total operating expenses
38,961
38,961
28,814
24,131
15,290
Operating income or loss
-38,961
-38,961
-28,814
-24,131
-15,290
Total other income/expenses net
530
530
-
6.634
185.28
Income before tax
-38,043
-38,043
-28,661
-24,122
-15,094
Income tax expense
-60
-60
-60
0
-
Income from continuing operations
-37,983
-37,983
-28,601
-24,122
-15,094
Net income
-37,983
-37,983
-28,601
-24,122
-15,094
Net income available to common shareholders
-37,983
-37,983
-28,601
-24,122
-15,094
Basic EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Diluted EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Basic average shares
10,931
12,222
7,056
5,552
1,981
Diluted average shares
10,931
12,222
7,056
5,552
1,981
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.